Referências

1. BRASIL, Vigitel. VIGILÂNCIA DE FATORES DE RISCO E PROTEÇÃO PARA DOENÇAS CRÔNICAS POR INQUÉRITO TELEFÔNICO. 2019. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2019_vigilancia_fatores_risco.pdf. Acesso em: 23 Jul. 2024.

2. WHO Consultation on Obesity (1999: Geneva, Switzerland) & World Health Organization. (2000). Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization. Disponível em: https://iris.who.int/handle/10665/42330.

3. Mapa da Obesidade. Disponível em: https://abeso.org.br/obesidade-e-sindrome-metabolica/mapa-da-obesidade/. Acesso em: 22 Jul. 2024.

4. WORLD OBESITY FEDERATION. World Obesity Atlas 2022. [s.l: s.n.]. Disponível em: https://s3-eu-west-1.amazonaws.com/wof-/World_Obesity_Atlas_2022.pdf. (accessed on 15 February 2023).

5. AISON K, I. et al. Psychological impact of obesity: A comprehensive analysis of health-related quality of life and weight-related symptoms. Obesity Medicine, v. 45, p./ 100530, 1 jan. 2024.

6. PATSALOS, O. et al. Diet, Obesity, and Depression: A Systematic Review. Journal of Personalized Medicine, v. 11, n. 3, 3 mar. 2021.

7. PROSPECTIVE STUDIES COLLABORATION. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. The Lancet, v. 373, n. 9669, p. 1083–1096, mar. 2009.

8. GRANT, B. et al. Managing obesity in people with type 2 diabetes. Clinical Medicine, v. 21, n. 4, p. e327–e231, jul. 2021.

9. YANG, M.; LIU, S.; ZHANG, C. The Related Metabolic Diseases and Treatments of Obesity. Healthcare, v. 10, n. 9, p. 1616, 1 set. 2022.

10. LIM, Y. Z. et al. Recommendations for weight management in osteoarthritis: A systematic review of clinical practice guidelines. Osteoarthritis and Cartilage Open, v. 4, n. 4, p. 100298, dez. 2022.

11. JEHAN, S. et al. Obstructive Sleep Apnea and Obesity: Implications for Public Health. Sleep medicine and disorders : international journal, v. 1, n. 4, 2017.

12. POLYZOS, S. A.; KOUNTOURAS, J.; MANTZOROS, C. S. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism, v. 92, p. 82–97, mar. 2019.

13. MALATY, H. Obesity and gastroesophageal reflux disease and gastroesophageal reflux symptoms in children. Clinical and Experimental Gastroenterology, p. 31, mar. 2009.

14. CALLE, E. E.; KAAKS, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews Cancer, v. 4, n. 8, p. 579–591, ago. 2004

15. BARBER, T. M. et al. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clinical Medicine Insights: Reproductive Health, v. 13, n. 13, p. 117955811987404, jan. 2019.

16. NAWAZ, S. et al. Obesity and chronic kidney disease: A current review. Obesity Science & Practice, v. 9, n. 2, 19 jul. 2022.

17. RADOMINSKI, Rosana Bento. Atualização das Diretrizes para o Tratamento Farmacológico da Obesidade e do Sobrepeso. Disponível em: https://abeso.org.br/wp-content/uploads/2019/12/Atualizacao-das-Diretrizes.pdf. Acesso em: 25 Jul. 2024

18. JIRAPINYO et al. American Society for Gastrointestinal Endoscopy–European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity. Endoscopy, v. 56, n. 06, p. 437–456, 19 abr. 2024.

19. HEDJOUDJE, A. et al. Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, v. 18, n. 5, p. 1043-1053.e4, maio 2020.

20. IBRAHIM MOHAMED, B. K.; BARAJAS-GAMBOA, J. S.; RODRIGUEZ, J. Endoscopic Bariatric Therapies: Current Status and Future Perspectives. JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, v. 26, n. 1, p. e2021.00066, 2022.

21. Cirurgia Bariátrica - Técnicas Cirúrgicas. Disponível em: https://www.sbcbm.org.br/tecnicas-cirurgicas-bariatrica. Acesso em: 23 de julho 2024.

22. EISENBERG, D. et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Obesity Surgery, v. 33, n. 1, 7 nov. 2022.

23. PATI, S. et al. Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. Cancers, v. 15, n. 2, p. 485, 12 jan. 2023.

24. ABU DAYYEH, B. K. et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointestinal Endoscopy, v. 82, n. 3, p. 425-438.e5, set. 2015

25. OLIVASDIGITAL. Ozempic: como age? Quanto emagrece? Tem efeitos colaterais? Tire 13 dúvidas. Disponível em: https://abeso.org.br/ozempic-como-age-quanto-emagrece-tem-efeitos-colaterais-tire-13-duvidas/. Acesso em: 23 de julho 2024.

26. BADURDEEN, D. et al. Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss. Gastrointestinal Endoscopy, v. 93, n. 6, p. 1316-1324.e1, jun. 2021.

27. ABESO. Semaglutida e liraglutida: entenda como as canetas contra obesidade agem no corpo (e seus riscos). Disponível em: https://abeso.org.br/semaglutida-e-liraglutida-entenda-como-as-canetas-contra-obesidade-agem-no-corpo-e-seus-riscos/. Acesso em: 26 jul. 2024.

28- Números baseados em dados internos da Boston Scientific - Apollo Surgery em relação à quantidade de dispositivos vendidos desde a autorização com o primeiro registro sanitário no ano de 2015 (FDA Approval)

29- COURCOULAS, A. et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. International Journal of Obesity, v. 41, n. 3, p. 427–433, 23 dez. 2016.

30- WEIGHT, M. Orbera® Managed Weight Loss System. Disponível em: https://www.orbera.com/safety-info. Acesso em: 25 ago. 2024.

31- WEIGHT, M. Orbera® Managed Weight Loss System. Disponível em: https://www.orbera.com/faqs. Acesso em: 25 ago. 2024.

32- ABU DAYYEH, B. K. et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet (London, England), v. 400, n. 10350, p. 441–451, 6 ago. 2022.

33. JAIN, D. et al. Endoscopic Sleeve Gastroplasty - A New Tool to Manage Obesity. Clinical Endoscopy, v. 50, n. 6, p. 552–561, 30 nov. 2017.

34. DIOGO et al. Perspectives toward minimizing the adverse events of endoscopic sleeve gastroplasty. v. 92, n. 5, p. 1115–1121, 1 nov. 2020.

35. Instrução de Uso do produto Overstitch aprovada pela ANVISA – data de inclusão: 30/10/2023

36- Instrução de Uso do produto BIB aprovada pela ANVISA – data de inclusão: 30/10/2023

37. RUBINO, F. et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care, v. 39, n. 6, p. 861–877, 24 maio 2016.

38. CUMMINGS, D. E. et al. Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery. New England Journal of Medicine, v. 346, n. 21, p. 1623–1630, 23 maio 2002.

39. O’BRIEN, P. E. et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obesity Surgery, v. 29, n. 1, p. 3–14, 6 out. 2018.

41. YOON, J. Y.; ARAU, R. T. The Efficacy and Safety of Endoscopic Sleeve Gastroplasty as an Alternative to Laparoscopic Sleeve Gastrectomy. Clinical Endoscopy, v. 54, n. 1, p. 17–24, 30 jan. 2021.

42. Endoscopic Sleeve Gastroplasty (ESG). Safety Information for Patients. Disponível em: https://www.apolloendosurgery.com/us/en/esg.html. Acesso em: 25 ago. 2024.

43. Endoscopic Sleeve Gastroplasty (ESG). Learn more about ESG. Disponível em: https://www.apolloendosurgery.com/us/en/esg.html. Acesso em: 25 ago. 2024.

44. STAHL, J. M.; MALHOTRA, S. Obesity Surgery Indications and Contraindications. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30020657/. Acesso em: 25 ago. 2024.

45. BERTI, L. V. et al. POSITION OF THE SBCBM - NOMENCLATURE AND DEFINITION OF OUTCOMES OF BARIATRIC AND METABOLIC SURGERY. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), v. 28, n. suppl 1, p. 2–2, 2015.

46. MOON, R. C.; TEIXEIRA, A. F.; JAWAD, M. A. Treatment of Weight Regain Following Roux-en-Y Gastric Bypass: Revision of Pouch, Creation of New Gastrojejunostomy and Placement of Proximal Pericardial Patch Ring. Obesity Surgery, v. 24, n. 6, p. 829–834, 21 jan. 2014.

47. RODRÍGUEZ-RODRÍGUEZ, R.; MIRALPEIX, C. Hypothalamic Regulation of Obesity. International Journal of Molecular Sciences, v. 22, n. 24, p. 13459, 15 dez. 2021.

49. MASELLI, D. B. et al. Revisional endoscopic sleeve gastroplasty of laparoscopic sleeve gastrectomy: an international, multicenter study. Gastrointestinal Endoscopy, v. 93, n. 1, p. 122–130, jan. 2021.

50. ABU DAYYEH, B. K.; LAUTZ, D. B.; THOMPSON, C. C. Gastrojejunal Stoma Diameter Predicts Weight Regain After Roux-en-Y Gastric Bypass. Clinical Gastroenterology and Hepatology, v. 9, n. 3, p. 228–233, mar. 2011.

51. BRUNALDI, V. O. et al. Argon plasma coagulation alone versus argon plasma coagulation plus full-thickness endoscopic suturing to treat weight regain after Roux-en-Y gastric bypass: a prospective randomized trial (with videos). Gastrointestinal Endoscopy, v. 92, n. 1, p. 97-107.e5, jul. 2020.

52. REDAÇÃO SOBED. Parecer técnico do Núcleo de Endoscopia Bariátrica da SOBED sobre: O tratamento endoscópico do reganho de peso pós-Derivação Gástrica. Disponível em: https://www.sobed.org.br/sobed-comunicacao/noticias/single/nid/parecer-tecnico-do-nucleo-de-endoscopia-bariatrica-da-sobed-sobre-o-tratamento-endoscopico-do-reganho-de-peso-pos-derivacao-gastrica. Acesso em: 25 ago. 2024.

53. DONNA MARIA ABBOUD et al. Tubularization of the gastric pouch helps sustain weight loss after transoral outlet reduction for post-Roux-en-Y gastric bypass weight recurrence. Endoscopy International Open, v. 11, n. 09, p. E829–E834, 26 jun. 2023.

54. BANREET SINGH DHINDSA et al. Efficacy of transoral outlet reduction in Roux-en-Y gastric bypass patients to promote weight loss: a systematic review and meta-analysis. Endoscopy International Open, v. 08, n. 10, p. E1332–E1340, 22 set. 2020.

55. DOLAN, R. D.; JIRAPINYO, P.; THOMPSON, C. C. Endoscopic versus surgical gastrojejunal revision for weight regain in Roux-en-Y gastric bypass patients: 5-year safety and efficacy comparison. Gastrointestinal Endoscopy, jun. 2021.

56. Consenso - Sociedade Brasileira de Cirurgia Bariátrica e Metabólica. Disponível em: https://www.sbcbm.org.br/consenso/.

57. [GHONEIM, Hossam; HAMZA, Iman. Intragastric Balloon (BIB) for the Management of Obesity, Report on the First Egyptian Experience. Open Journal Of Gastroenterology, [S.L.], v. 04, n. 08, p. 295-304, 2014. Scientific Research Publishing, Inc.. http://dx.doi.org/10.4236/ojgas.2014.48043.]

58. JÚNIOR, João Remí de Freitas; KOTINDA, Ana Paula Samy; SAGAE, Vitor Massaro Takamatsu; FUNARI, Mateus Pereira; MOURA, Eduardo G. Horneaux. BALÃO INTRAGÁSTRICO ENDOSCÓPICO E SUAS INDICAÇÕES. Sociedade Brasileira de Endoscopia Digestiva, 2021.

59. Orbera. Disponível em: https://www.apolloendosurgery.com/us/en/orbera.html#accordion-198e517d92-item-dd862ac39d. Acesso em: 27 ago. 2024.

60. OrberaTM Intragastric Balloon System. Disponível em: https://www.bostonscientific.com/en-US/products/endoluminal-surgery-devices/orbera-intragastric-balloon-system.html. Acesso em: 28 ago. 2024.

61. CHENG, Q. et al. Reversal of endoscopic sleeve gastroplasty and conversion to sleeve gastrectomy – Two case reports. International Journal of Surgery Case Reports, v. 68, p. 180–184, 2020.

62. VALEZI -PR, C. et al. [s.l: s.n.]. Disponível em: https://www.sbcbm.org.br/wp-content/uploads/2021/10/Manual-de-Diretrizes-de-Codificac%CC%A7a%CC%83o-em-Cirurgia-Bariatrica-e-Metabolica-1.pdf.

63. BOŠKOSKI, I. et al. Redo endoscopic sleeve gastroplasty: technical aspects and short-term outcomes. Therapeutic Advances in Gastroenterology, v. 13, p. 1756284819896179, 20 jan. 2020. https://www.apolloendosurgery.com/us/en/orbera.html#accordion-198e517d92-item-0816719a53. Acesso em: 28 ago. 2024.